Additional file 2: Figure S1. of Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

Plot of pneumonia incidence per 1000 patient-years and 95% CI by treatment group (integrated clinical studies). BD, twice daily; CI, confidence interval; FF, fluticasone furoate; FP, fluticasone propionate; OD, once daily. (TIF 465 kb

Additional file 3: Figure S2. of Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

Plot of serious pneumonia incidence per 1000 patient-years and 95% CI by treatment group (integrated clinical studies). BD, twice daily; CI, confidence interval; FF, fluticasone furoate; FP, fluticasone propionate; OD, once daily. (TIF 427 kb

Additional file 7: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Summary of exposure in each treatment arm (Safety population). (DOCX 26.5 KB